| First Author | Chen L | Year | 2006 |
| Journal | Neurobiol Dis | Volume | 23 |
| Issue | 1 | Pages | 120-6 |
| PubMed ID | 16713278 | Mgi Jnum | J:111193 |
| Mgi Id | MGI:3653276 | Doi | 10.1016/j.nbd.2006.02.004 |
| Citation | Chen L, et al. (2006) Proteasome dysfunction in aged human alpha-synuclein transgenic mice. Neurobiol Dis 23(1):120-6 |
| abstractText | A deficit in proteasome function in Parkinson's disease has been speculated. We characterized the ubiquitin-proteasome system in three regions of brain from transgenic and nontransgenic littermates. Mice expressing a doubly mutated form of human alpha-synuclein had significant impairments whereas mice expressing the wild-type gene had lesser changes compared to nontransgenic littermates. Significant abnormalities in line hm2 alpha-SYN-39 included declines in 20S-mediated proteolytic activity, the level of the 19S proteasome subunits Rpt1 and Rpn2, and the level of soluble total high MW ubiquitin cross-reacting proteins. Line hw alpha-SYN-5 had significant, but restricted proteasome abnormalities. The severity of impairment was proportional to the substantia nigra dopaminergic neuronal loss previously identified. There were significant correlations between the level of Rpn2 with the level of Rpt1, the activity of the 20S proteasome, and the level of soluble high MW ubiquitin cross-reacting proteins. These abnormalities in symptomatic line hm2 alpha-SYN-39 mice are consistent with abnormalities identified in tissue from patients with Parkinson's disease. |
